BLACK WEEKSFrascos −15% · kits −10% · resto −5%com o códigoEnvio grátis na Alemanha a partir de 200 €

Esta página foi traduzida automaticamente e pode conter erros. É falante nativo? Agradecemos o seu feedback e as suas correções.Enviar feedback

The Peptide Desk The Peptide Desk
GHK-Cu + KPV Blend, foto do produto

Relatório laboratorial

PDF
99%
Pureza
Testado
GHK-Cu + KPV Blend 60mg
Laboratório
Analiza Białek
Data
October 2026
Resultado
99% purity (GHK-Cu 95.54 mg + KPV 10.91 mg, 50 + 10 mg label)
Endotoxinas
6.88 EU/vial
N.º da encomenda
Palavra-passe

Testado de forma independente, verificável com a palavra-passe diretamente no laboratório.

Healing

GHK-Cu + KPV Blend

Healing

Encomenda

Preço unitário - Envio grátis na Alemanha a partir de 200 € durante as Black Weeks
  • DHL com seguimento
  • Embalagem discreta

4.6 de 5 no Trustpilot73 avaliações

Conhecimento

Tudo sobre GHK-Cu + KPV Blend

Informação detalhada disponível em breve.

Convém ter

O que precisa para isto

A água bacteriostática é adicionada automaticamente ao carrinho. Seringas e toalhetes com um clique.

Seringas de insulina

10 un. · 5.50 €

Toalhetes com álcool

50 un. · 10 €

Quanta água?

Unidades na seringa para o tamanho do seu frasco.

Abrir calculadora →

FAQ

Perguntas frequentes

Fontes de cada resposta: entrada da enciclopédia

Ainda tem alguma pergunta?

Escreva-nos, a nossa equipa ajuda.

Are there studies on the GHK-Cu + KPV Blend?

No. As of 26 October 2026 there is no study on the blend, neither on ClinicalTrials.gov nor in PubMed. The only paper naming both peptides is a review of tripeptides in wound healing without its own data on the blend. Only the single components have been studied.

Why these two peptides?

The idea is that the pathways complement each other: GHK-Cu on the side of building and collagen, KPV on the side of calming inflammation. This has not been tested. No study has examined whether the combination does more than either substance alone.

What is known about GHK-Cu in humans?

The best study is a randomised gel trial in diabetic foot ulcers: a median 98.5 percent of the wound area closed, versus 60.8 percent with vehicle gel. Other data come mainly from cosmetics. A recent review calls the clinical evidence sparse, there are no studies on injection.

What is known about KPV?

KPV enters gut and immune cells via the transporter PepT1 and inhibits the inflammation pathway NF-κB there even at nanomolar concentrations. In two colitis models in mice KPV in the drinking water reduced inflammation. In nanoparticles a 12,000-fold lower concentration was enough. In skin cells KPV triggered a calcium signal. There are no human studies.

Which side effects are known?

There are no data for the blend. In the GHK-Cu gel trial 7 percent of ulcers became infected, versus 34 percent with vehicle gel. Human safety data are missing for KPV and for GHK-Cu as an injection. A review of peptides in sport warns that robust safety data are missing for many of these substances.

Is the blend approved?

No. Neither the blend nor GHK-Cu or KPV is approved as a medicine (as of October 2026). ChEMBL lists GHK without a clinical phase and no trial of KPV is registered.

Relacionados

Produtos relacionados